Cara Crumlish

Cara Crumlish is an accomplished professional with extensive experience in the pharmaceutical and healthcare sectors, currently serving as the Director of Integrated Evidence Generation Program Lead in Neuroscience at Jazz Pharmaceuticals since April 2021, after a prior role as Associate Director. Prior to Jazz Pharmaceuticals, Cara held various positions at GSK, including Contract Development Manager in Managed Markets and Government Affairs, and Project Manager in US Medical Affairs for the vaccine launch of SHINGRIX. Additional experience includes roles at The Janssen Pharmaceutical Companies, Gilead Sciences, BioClinica, and internships at Drexel University and the City of Philadelphia’s Department of Public Health. Cara holds a Master of Public Health from Drexel University and a Bachelor of Arts in History and Spanish from Temple University.